Search Within

Alexander Noor Shoushtari

  1. "Charlotte Ariyan"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
  3. Research Letter (2)
  4. Editorial (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (17)
  2. Hematologic Malignancies, Division of (17)
  3. Melanoma Disease Management Team (17)
  4. Melanoma and Immunotherapeutics Service (17)
  5. Solid Tumor Oncology Division (17)
  6. Surgery (17)

More Groups

People
  1. Charlotte Ariyan (17)
  2. Michael Postow (10)
  3. Daniel Coit (8)
  4. Jedd Wolchok (8)
  5. Margaret Callahan (8)
  6. Paul Chapman (8)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (3)

More Years

Publications
  1. Annals of Surgical Oncology (3)
  2. Journal of Clinical Oncology (3)
  3. Nature Genetics (2)
  4. American Journal of Surgical Pathology (1)
  5. British Journal of Dermatology (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. American Society of Clinical Oncology (3)
  3. Springer (3)
  4. American Association for Cancer Research (1)
  5. Blackwell Publishing (1)
  6. Elsevier Inc. (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Journal Article

    Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Most large structural variants in cancer genomes can be detected without long reads
    Journal Article

    Choo, Z. N.; Behr, J. M.; Deshpande, A.; Hadi, K.; Yao, X.; Tian, H.; Takai, K.; Zakusilo, G.; Rosiene, J.; Da Cruz Paula, A.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)
    Editorial

    Wei, A. Z.; Chen, L. N.; Orloff, M.; Ariyan, C. E.; Asgari, M.; Barker, C. A.; Buchbinder, E.; Chandra, S.; Couts, K.; Frumovitz, M. M.; more...
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Meeting Abstract

    Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant relatlimab and nivolumab in resectable melanoma
    Journal Article

    Amaria, R. N.; Postow, M.; Burton, E. M.; Tezlaff, M. T.; Ross, M. I.; Torres-Cabala, C.; Glitza, I. C.; Duan, F.; Milton, D. R.; Busam, K.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma
    Research Letter

    Kurtansky, N. R.; Manci, R. N.; Bello, D. M.; Adamson, A. S.; Shoushtari, A. N.; Wehner, M. R.; Ariyan, C. E.; Marghoob, A. A.; Marchetti, M. A.; Rotemberg, V.
    British Journal of Dermatology (2022)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Response to checkpoint blockade and survival in patients with stage III melanoma
    Meeting Abstract

    Theriot, J.; Bello, D.; Lobaugh, S.; Bartlett, E. K.; Betof, A.; Shoushtari, A.; Postow, M.; Callahan, M.; Brady, M. S.; Wong, R.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade
    Journal Article

    Bello, D. M.; Panageas, K. S.; Hollmann, T.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save